Track topics on Twitter Track topics that are important to you
Lundbeck has announced that the first late-stage trial of its experimental Alzheimer's disease candidate idalopirdine failed to hit its primary targets.
Original Article: Lundbeck reveals Alzheimer’s drug trial failureNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...